With AbbVie in its sights, Tenpoint names commercial chief ahead of vision drug launch
Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly appointed chief commercial officer, Kearney will oversee preparations to launch a rival to AbbVie’s age-related blurry near vision product Vuity.
Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly appointed chief commercial officer, Kearney will oversee preparations to launch a rival to AbbVie’s age-related blurry near vision product Vuity.
